TEVA PHARMACEUTICAL INDUSTRIES 2AbstractTeva Pharmaceutical Industries make different types of antibiotics. The product lines of the company include the equivalent of osteoporosis drug Fosamax and blockbusters as antidepressant Prozac. This paper will majorly focus on the products that Teva produces. It will analyse how the company competes with other companies in the industry, and how it attempts to put up with the competition in the last few years. The paper will evaluate the resources of Teva, and identify the most valuable ones. In addition, the opportunities for Tevain biosimilars and innovative pharmaceutical will be analysed. Thus, showing some of the benefits the company has incurred due to the introduction of biosimilars. Finally, the paper will explain the competitive advantage of the company. It will then suggest a way forward forthe company given the stiff competition.
TEVA PHARMACEUTICAL INDUSTRIES 3IntroductionTeva is a drug and pharmaceutical company based in Israel. It produces, develops and distributes generic drugs in many treatment categories. The principal products of the company include azilet and Copaxone. Tevas worldwide operations are mainly conducted from Latin and North America to Asia and Europe. The company manages a number of branches in countries like Croatia, Canada, Germany, France, Hungary, Ireland, Israel, Japan Poland, the United Kingdom, and even the United States of America. Teva deals in a wide range of products. The main products include the generic pharmaceutical, and the most currently introduced product is the biosimilars. They will move the company to a higher leveleven with the competition.